Literature DB >> 8698399

Analysis of immunoglobulin variable region genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitis.

C Longhurst1, M R Ehrenstein, B Leaker, F K Stevenson, M Spellerberg, C Chapman, D Latchmen, D A Isenberg, G Cambridge.   

Abstract

Circulating antibodies to myeloperoxidase (MPO) are associated primarily with pauci-immune glomerulonephritis and systemic vasculitis. Anti-MPO antibodies belong to a group of autoantibodies, anti-neutrophil cytoplasmic antibodies, that may play a pathogenic role in vasculitis. We have generated a human monoclonal anti-MPO antibody (E3-MPO) using peripheral blood lymphocytes from a patient with microscopic polyarteritis. Variable region gene analysis of E3-MPO showed that the VH region had 90% homology with the germ line gene VH4-21. E3-MPO was also shown to carry the 9G4 idiotope, which so far has been associated only with human antibodies that utilize the VH4-21 gene. The 9G4 idiotope was also expressed on anti-MPO antibodies in sera from the donor patient and from 4/7 additional patients with active, untreated vasculitis. The nucleotide sequences of both the variable heavy and light chains of E3-MPO showed evidence of an antigen-driven response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698399      PMCID: PMC1384293          DOI: 10.1046/j.1365-2567.1996.463529.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells.

Authors:  B H Ewert; J C Jennette; R J Falk
Journal:  Kidney Int       Date:  1992-02       Impact factor: 10.612

Review 2.  VH4-21, a human VH gene segment overrepresented in the autoimmune repertoire.

Authors:  V Pascual; J D Capra
Journal:  Arthritis Rheum       Date:  1992-01

3.  Ig H and L chain contributions to autoimmune specificities.

Authors:  M Z Radic; M A Mascelli; J Erikson; H Shan; M Weigert
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

4.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction.

Authors:  G G Hunder; W P Arend; D A Bloch; L H Calabrese; A S Fauci; J F Fries; R Y Leavitt; J T Lie; R W Lightfoot; A T Masi
Journal:  Arthritis Rheum       Date:  1990-08

5.  Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure.

Authors:  D E Roberts; C Peebles; J G Curd; E M Tan; R L Rubin
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

6.  Severe pulmonary hemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasm antibodies of IgM class only.

Authors:  D R Jayne; S J Jones; A Severn; S Shaunak; J Murphy; C M Lockwood
Journal:  Clin Nephrol       Date:  1989-09       Impact factor: 0.975

7.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Authors:  R J Falk; S Hogan; T S Carey; J C Jennette
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

Review 8.  The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement.

Authors:  B Chang; P Casali
Journal:  Immunol Today       Date:  1994-08

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis.

Authors:  F Rossi; D R Jayne; C M Lockwood; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

View more
  5 in total

1.  A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions.

Authors:  I C Locke; B Leaker; G Cambridge
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.

Authors:  L S Jeffs; C A Peh; A Nelson; P G Tan; E Davey; K Chappell; G B Perkins; P R Hurtado
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 3.  B cells and immunological tolerance.

Authors:  Nataly Manjarrez-Orduño; Tâm D Quách; Iñaki Sanz
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

4.  Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition.

Authors:  Ravi S Keshari; Anupam Jyoti; Megha Dubey; Nikhil Kothari; Monica Kohli; Jaishri Bogra; Manoj K Barthwal; Madhu Dikshit
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

Review 5.  Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren's Syndrome: Clues for a Personalized Medicine.

Authors:  Luca Quartuccio; Ginevra De Marchi; Simone Longhino; Valeria Manfrè; Maria Teresa Rizzo; Saviana Gandolfo; Alberto Tommasini; Salvatore De Vita; Robert Fox
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.